Vivos Therapeutics, Inc. - SIC # 8081 -

Ticker Exchange SIC # Website Latest Ticker
VVOS Nasdaq 8081 www.vivos.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Vivos Therapeutics, Inc.

Vivos Therapeutics (VVOS) Stock Fair Value Falls After Analyst Target Cuts - Jul 18th, 2026 11:07 am
Vivos Therapeutics (VVOS) Stock Sees Fair Value Moves Lower As Analysts Reset Growth Assumptions - Jul 3rd, 2026 7:17 am
Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants - Jun 30th, 2026 6:45 am
Sector Update: Healthcare Stocks Rise Late Afternoon - Jun 22nd, 2026 1:43 pm
Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity - Jun 22nd, 2026 6:30 am
Vivos Therapeutics Plans to File for Proposed Rights Offering - Jun 11th, 2026 7:11 am
Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering - Jun 11th, 2026 6:30 am
Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients - Jun 10th, 2026 7:03 am
Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026 - Jun 8th, 2026 11:39 am
Sector Update: Healthcare Stocks Higher Late Afternoon - Jun 5th, 2026 1:49 pm
Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing - Jun 5th, 2026 6:45 am
Vivos Therapeutics Inc (VVOS) Q1 2026 Earnings Call Highlights: Revenue Surges Amid Strategic Shifts - May 28th, 2026 7:02 pm
Vivos Therapeutics, Inc. Q1 2026 Earnings Call Summary - May 21st, 2026 10:54 am
Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update - May 20th, 2026 2:10 pm
Plus Therapeutics (PSTV) Reports Q1 Loss, Tops Revenue Estimates - May 15th, 2026 3:20 pm
New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Vivos Therapeutics (NASDAQ:VVOS) - Apr 18th, 2026 8:00 am
Vivos Therapeutics Inc (VVOS) Q4 2025 Earnings Call Highlights: Revenue Growth Amid Strategic ... - Apr 16th, 2026 1:01 am
Vivos Therapeutics Reports Full Year 2025 Financial Results - Apr 15th, 2026 2:20 pm
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call - Apr 15th, 2026 6:45 am
Vivos Therapeutics, Inc. Q4 2025 Earnings Call Summary - Apr 15th, 2026 6:30 am